SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001682852-23-000033
Filing Date
2023-10-16
Accepted
2023-10-16 08:59:03
Documents
12
Period of Report
2023-10-16
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K mrna-20231016.htm   iXBRL 8-K 30343
  Complete submission text file 0001682852-23-000033.txt   156356

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrna-20231016.xsd EX-101.SCH 1907
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrna-20231016_lab.xml EX-101.LAB 23834
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrna-20231016_pre.xml EX-101.PRE 12512
6 EXTRACTED XBRL INSTANCE DOCUMENT mrna-20231016_htm.xml XML 2807
Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 6177146500
Moderna, Inc. (Filer) CIK: 0001682852 (see all company filings)

IRS No.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38753 | Film No.: 231326357
SIC: 2836 Biological Products, (No Diagnostic Substances)